At Holdings Channel, we have reviewed the latest batch of the 63 most recent 13F filings for the 09/30/2026 reporting period, and noticed that Merck & Co Inc (Symbol: MRK) was held by 41 of these funds.  When hedge fund managers appear to be thinking alike, we find it is a go

See Which Recent 13F Filers Hold MRK

The S&P 500 Index ($SPX ) (SPY ) is up by +0.13% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.57%.  December E-mini S&P futures (ESZ26 ) are up +0158%, and December E-mini...

Stock Indexes Rebound as Investors Rotate Out of Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) is down by -0.57% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.71%.  December E-mini S&P futures (ESZ26 ) are down -0.58%, and December E-mini...

Stocks Pressured as Chipmaker Selloff Deepens

The S&P 500 Index ($SPX ) (SPY ) closed down by -1.11% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.02%.  December E-mini S&P futures (ESZ26 ) fell -1.16%, and December E-mini...

Stocks Sharply Lower on Inflation Woes and Slumping Chipmakers

In trading on Wednesday, the VanEck Pharmaceutical ETF is outperforming other ETFs, up about 2.9% on the day.  Components of that ETF showing particular strength include shares of Astrazeneca, up about 4.4% and shares of Merck, up about 4.2% on the day.

And underperforming othe

Wednesday's ETF Movers: PPH, SILJ  

The S&P 500 Index ($SPX ) (SPY ) is down by -0.75% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.11%.  December E-mini S&P futures (ESZ26 ) are down -0.80%, and December E-mini...

Stocks and Bonds Fall on a Strong CPI Report

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Merck & Co., Inc. News